Hepatic encephalopathy primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==Primary Prevention== | ==Primary Prevention== | ||
Usage of lactulose is helpful in prevention of HE in patients with cirrhosis and acute variceal bleeding.<ref name="pmid21129028">{{cite journal| author=Sharma P, Agrawal A, Sharma BC, Sarin SK| title=Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose. | journal=J Gastroenterol Hepatol | year= 2011 | volume= 26 | issue= 6 | pages= 996-1003 | pmid=21129028 | doi=10.1111/j.1440-1746.2010.06596.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21129028 }} </ref> | Usage of [[lactulose]] is helpful in prevention of HE in patients with [[cirrhosis]] and acute [[variceal bleeding]].<ref name="pmid21129028">{{cite journal| author=Sharma P, Agrawal A, Sharma BC, Sarin SK| title=Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose. | journal=J Gastroenterol Hepatol | year= 2011 | volume= 26 | issue= 6 | pages= 996-1003 | pmid=21129028 | doi=10.1111/j.1440-1746.2010.06596.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21129028 }} </ref> | ||
Usage of lactitol or rifaximin is not effective in the prophylaxis of hepatic encephalopathy during the first month after a transjugular-intrahepatic-portosystemic-shunt (TIPS). | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 17:40, 12 January 2018
|
Hepatic encephalopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatic encephalopathy primary prevention On the Web |
|
American Roentgen Ray Society Images of Hepatic encephalopathy primary prevention |
|
Risk calculators and risk factors for Hepatic encephalopathy primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
Primary Prevention
Usage of lactulose is helpful in prevention of HE in patients with cirrhosis and acute variceal bleeding.[1]
Usage of lactitol or rifaximin is not effective in the prophylaxis of hepatic encephalopathy during the first month after a transjugular-intrahepatic-portosystemic-shunt (TIPS).
References
- ↑ Sharma P, Agrawal A, Sharma BC, Sarin SK (2011). "Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose". J Gastroenterol Hepatol. 26 (6): 996–1003. doi:10.1111/j.1440-1746.2010.06596.x. PMID 21129028.